Background: Pleural effusion is the pathologic accumulation of fluid in the pleural space. The fluid analysis yields important diagnostic information, and in certain cases, fluid analysis alone is enough for diagnosis. Analysis of pleural fluid by thoracentesis with imaging
INTRODUCTION
Pleural effusion is the pathologic accumulation of fluid in the pleural space which results when forces that control the inflow and outflow of the space are disrupted 1 . Pleural effusion can result from numerous pathologic conditions, such as congestive heart failure, pneumonia, pleuropulmonary malignancy, connective tissue diseases, and trauma 2, 3 .
The pleural effusion is evaluated by whether pleural fluid is a transudate or an exudate. Transudate is caused by imbalances in hydrostatic and oncotic forces. The main cause of transudates is usually congestive heart failure (CHF), kidney failure, and cirrhosis. In contrast, exudates occur when local factors influencing the accumulation of pleural fluid are altered. Exudates are due to the increased capillary permeability and/or impaired lymphatic drainage which results from the proliferative (e.g. malignancy) or inflammatory (e.g. parapneumonic effusions) processes 4 
.
Diagnostic thoracentesis is performed to determine the specific cause of a pleural effusion and supplies biochemistry measurements (e.g. protein and LDH) that help to separate effusions into transudates and exudates. Further analysis such as cytology and cultures may help in establishing the specific cause of the effusion 5 . Though diagnostic thoracentesis is considered a relatively safe procedure, it is associated with risks such as pneumothorax and has several contraindications such as coagulopathy 6, 7, 8 . Thus, a noninvasive method to characterize pleural fluid would be valuable for avoiding the potential risks associated with thoracentesis and may help to guide therapy. In addition, such a method could help with diagnosis in patients with a contraindication for the invasive procedure.
The differential diagnosis of pleural effusions can be conducted by means of thoracentesis, pleural biopsies, and occasionally diagnostic thoracoscopy 9 and imaged by radiography 10 , ultrasonography 11 or computed tomography (CT) 12 . Noninvasive procedure like CT scan be useful in determining the causes of pleural effusions 13, 14 . CT is commonly used to evaluate patients with pleural abnormalities related to neoplasm, pneumonia, and empyema 15 . Indeed, CT can be used to evaluate the nature of pleural effusions to avoid the complications of thoracentesis 6, 7 .
Features such as pleural nodules, pleural thickening, loculation, and effusion density can be evaluated by CT to discriminate between exudates and transudates 16 . Analysis of pleural fluid by thoracentesis with imaging guidance helps to determine the cause of pleural effusion. In this regard, the objective of this study was to assess the utility of Multidetector Computed Tomography (MDCT) examinations in characterizing pleural effusions on the basis of attenuation values and CT appearance.
MATERIALS AND METHODS

Study design and patient selection
The study protocol was reviewed and approved by the Gandaki Medical College and Teaching Hospital's Institutional Ethics Committee. This prospective study included patients who had a chest CT followed by diagnostic thoracentesis within 48 hours who visited between January 1, 2017 and Feb 28, 2018. Informed consent was obtained from the each patient for this study.
The patients were categorized into transudates and exudates groups according to the types of pleural effusion by using Light's criteria 17 , which diagnoses exudates pleural fluid when one or more of the following criteria is meet: (a) a pleural fluid total protein/serum total protein ratio>0.5, (b) pleural fluid lactic dehydrogenase (LDH)/ serum LDH ratio >0.6, or (c) pleural fluid LDH >two-thirds of the upper limits of the normal serum LDH value. CT attenuation value (CTA) in Hounsfield Unit (HU) was taken using a region of interest on the CT chest with the greatest quantity of fluid. Each CT scan was also reviewed for the presence of additional pleural features such as pleural thickening, loculation and pleural nodule.
Inclusion Criteria
This study included patients with pleural effusions on CT scan and who underwent diagnostic thoracentesis within 48 hours.
Exclusion Criteria
The patients were excluded from this study who underwent insertion of intercostals drainage before CT examination, and who had uncertain final diagnosis, had contrast media allergy, had serum creatinine greater 1.5 mg/dl, or had pregnancy.
CT protocol and imaging analysis
The pleural fluid CT attenuation value (CTA) in Hounsfield Unit were taken by using the average measure of the | Original Article three slices with the greatest quantity of fluid, which was determined by the largest anteroposterior diameter of the pleural effusion. A region of interest was placed for measurement of Hounsfield unit values of the maximal amount of fluid on each (Fig 1, 2 and 3 ). The Radiologist took care not to include adjacent ribs, lung parenchyma, or areas of pleural thickening. CT was performed on all patients using Toshiba Asteion 4 slice scanner, Japan. The protocol used for this scanning was contiguous axial 4 mm; pitch of 1; 120 kV; and automated mAs. IV contrast material was not administered when renal function tests were abnormal, in patients with high risk for contrast nephropathy (Dehydration, diabetes mellitus etc.), in patients with an allergy to contrast material, or when the indication for CT did not necessitate the use of contrast material. IV contrast material was administered in standard injection protocol (100 mL of iohexol 350 mg I/ml) at 1 -2 ml /kg with an injection rate of 3 mL/s.
Statistical Analysis
All samples data were tabulated in a master chart and entered in data sheet Graph pad prism version 7. Statistical analysis was carried out with Graph pad prism; a computer software program. The data were expressed as mean. Two tailed T-test were used for correlation between types of pleural effusion and mean attenuation value in pre and post contrast CT images. Receiver operating characteristic (ROC) curve was applied to find the CT attenuation values for exudates and cut-off point was identified using the ROC curve nearest to the point at which sensitivity and specificity were maximized. One way ANOVA test was applied for determining the correlation between subgroups of exudates pleural effusion and mean attenuation coefficient. Statistical significance was defined as P <0.05.
RESULTS
There were 100 people subjected to this study who were from different parts of the Western Region of Nepal. Among them 62 out of 100 were males (62%) and 38 out of 100 were females (38%). Among them youngest patient was 10 years old and oldest patient was 89 years old. The demographic and CT findings in patients with exudative and transudative effusions are shown in Table 1, Table 2 and and 100%) were obtained.
One way ANOVA test was applied for determining the correlation among sub group of exudates empyema, pulmonary tuberculosis and malignancy and mean attenuation coefficient which showed there were no significant correlation between subgroups of exudative pleural effusion with its mean coefficient value (p=0.57). 
DISCUSSION
The space between parietal and visceral pleura is known as pleural space. Normally 7 -14 ml of pleural fluid is found in the pleural space 18 . Accumulation of pleural fluid more than normal limit occurs when rate of the fluid formation exceeds the rate of the fluid removal. This may mostly result from either of increase of hydrostatic pressure (transudate) or increase of permeability of the pleural vessel (exudates) 19 . Differentiation between exudative and transudative pleural fluid relies on chemical analysis of pleural fluid and blood, by using Light criteria
17
. CT is commonly used tool for assessing the patient presenting with pleural abnormalities 15 . CT scan is not only useful tool for detecting type of pleural effusion but also useful for detecting the causes of pleural effusion and its associated lung, mediastinal and heart disease 13, 14 .
There are several studies which found the clinical application of the CT scan for differentiation between transudative and exudative pleural effusion by using CT attenuation value. The previous studies conducted by Nandalur et al 20 The results obtained in this study were similar to the prior studies 20, 21 which showed significant higher mean attenuation values of exudates (16.5 ±1.7 HU in postcontrast images and 15.5 ±0.5 HU in pre-contrast images), compared with the transudates (11.6 ±0.57 HU in postcontrast images and 10.5 ±0.2 HU in pre-contrast images). The mean attenuation values in post-contrast CT images were approximately one HU higher than those in precontrast images, which represented the small effect of intravenous contrast material to the mean attenuation values. Similar to the previous study done by Abramowitz et al 22 , this study also obtained negative attenuation value in nine out of 74 exudative fluid, among them two cases were lipoid pneumonia and seven cases were lung malignancy.
There are different reasons for causing elevation of pleural cholesterol in exudates rather than elevation of serum cholesterol level. Best possible reason for increased pleural cholesterols level may be due to greater cellular degeneration or increased pleural permeability in underlying disease e.g. malignancy, pneumonia or tuberculosis 23 . Other possible cause for elevating cholesterol levels can also result from chylothorax, mainly due to trauma or lymphoma, and from pseudochylothorax, mainly due to tuberculosis, rheumatoid arthritis, or empyema 24 . Since fat tissue demonstrate negative attenuation values. Thus, the high concentration of protein in exudates that is expected to raise the attenuation values may be contradicted by the high cholesterol level that decreases the CT attenuation value. We could not determine whether our negative attenuation fluids had high levels of cholesterol because pleural cholesterol was measured in only seven out of the 100 patients. 16 reported that CT findings, such as loculation and pleural thickening, appeared more frequently in empyemas but also occurred in pneumonic effusions; therefore, these findings cannot be used as a distinguishing feature. However, Cullu et al 21 found that patients with empyemas had a significantly higher frequency of loculation and pleural thickening than other patients. In our study, there was no statistically significant difference in the frequency of pleural loculation and pleural thickening between empyema patients and other patients. However, it was found that the frequency of loculation in patients with empyema was higher than that seen in patients without empyema, although this difference was not statistically significant (p=0.056).
Arenas-Jimenez et al
The authors Aquino et al
15 , Arenas-Jimenez 16 and Waite et al 25 found that the presence of pleural thickening, pleural nodules and loculation were highly specific for exudates. Similarly, Cullu et al 21 reported that exudates had a significantly higher frequency of loculation and pleural thickening compared to that of transudates. However, Abramowitz et al 22 found pleural thickening in 8 out of 22 transudates (36%) compared to 46 out of 78 exudates (59%), and loculated pleural effusion in eight of the 22 transudates (36%) compared with 45 of the 78 exudates (58%). Both pleural thickening and loculation were found in more than one-third of patients with transudates, which was not in line with previous studies. In our study, similarly to Abramowitz et al 22 , we found that the presence of pleural thickening, pleural nodules and loculation were not reliable findings for characterizing pleural effusions though frequency of pleural thickening, loculation and pleural nodules were higher in exudative pleural effusion.
CONCLUSION
In conclusion, we believe that CT attenuation values may be useful in differentiating exudates from transudates. Although there is an overlap in the majority of effusions, 
